Add BrightSurf on Google Email

Science News for June 13, 2002


Acarbose could delay onset of type-2 diabetes

In a large clinical trial, patients with impaired glucose tolerance who took acarbose were 25% less likely to develop type-2 diabetes than those taking placebo. Acarbose also helped reversion of impaired glucose tolerance to normal glucose tolerance. The main side effects were flatulence and diarrhea.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 13, 2002

Eye drops can delay onset of glaucoma

A recent study found that eye drops can delay the onset of glaucoma by reducing intraocular pressure by approximately 20%. The Ocular Hypertension Treatment Study (OHTS) followed 1,636 participants with elevated eye pressure and showed a significant reduction in glaucoma development among those who received treatment. This breakthrough...

SourceWashU Medicine·JournalArchives of Ophthalmology·DateJun 13, 2002

Tobacco money – Up in smoke?

Researchers argue that NY-ELCAP cannot determine if spiral CT screening saves lives due to a lack of control group. The study's design flaw could lead to overdiagnosis and unnecessary treatment for some participants.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 13, 2002